Owens & Minor is a global healthcare logistics company that specializes in the distribution of medical supplies and products to hospitals, healthcare providers, and other organizations within the healthcare industry
The company provides a range of services, including inventory management, supply chain solutions, and the development of customized healthcare products, ensuring that healthcare providers have timely access to the essential medical items needed to deliver quality patient care. By leveraging technology and comprehensive logistics capabilities, Owens & Minor aims to enhance the efficiency of healthcare operations and improve overall patient outcomes.
Shares of medical supply and logistics company Owens & Minor (NYSEOMI) jumped 36.9% in the afternoon session after the company reported impressive fourth quarter 2024 results, exceeding analysts' EBITDA and EPS expectations despite delivering in-line revenue. Full-year revenue guidance was also in line, which is comforting. On the other hand, its full-year EPS guidance fell short of Wall Street's estimates. Overall, the quarter was solid, with strong revenue growth, improving margins, and positive guidance.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Medical supply and logistics company Owens & Minor (NYSEOMI) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 1.5% year on year to $2.70 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $11 billion at the midpoint. Its non-GAAP profit of $0.55 per share was 5.7% above analysts’ consensus estimates.
Owens & Minor beat Q4 EPS and revenue estimates, announced a $100M buyback, and provided 2025 guidance, projecting double-digit adjusted EBITDA growth.
Shareholders of Owens & Minor would probably like to forget the past six months even happened. The stock has dropped 49.9% and now trades at a new 52-week low of $7.77. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSEOMI) family, recently launched ByramConnectTM, a personalized digital health program powered by the Welldoc App®. Using the Welldoc App’s advanced artificial intelligence capabilities, the program analyzes member data across six dimensions of health to help optimize outcomes for people with type 1 or type 2 diabetes and associated chronic conditions such as hypertension, weight management, and cardiovascular risk, providing Byram members with actionable insights and reports that can be shared with their providers and care teams.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Owens & Minor shares dipped after disclosing preliminary results and financing for the Rotech Healthcare Holdings, Inc. buyout. The company expects to close the deal in the first half of 2025 and sees significant synergy opportunities. Preliminary results for Q4 and 2024 were also provided.
Owens & Minor, Inc. (NYSEOMI) (the “Company”) today announced selected preliminary financial results for the fourth quarter and year ended December 31, 2024 in advance of its upcoming earnings announcement and conference call. The release of the preliminary results relates to the Company’s commencement of financing activity related to its previously announced agreement to acquire Rotech Healthcare Holdings, Inc (“Rotech”).
